Reached alignment with FDA on key elements of registrational development plan for LX2006, including accelerated approval ...
Revenue: Total revenue was $2.1 million for the quarter ended September 30, 2024, comprised of $0.6 million in net product ...
Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for ...
CARMAT's Aeson® artificial heart is gradually becoming a reference solution for bridge to transplant in Europe.
News Medical on MSN18h
Machine learning helps predict stroke risk after CF-LVAD implantationSome patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device ...
SUNY Poly Assistant Professor Dr. Amit Sangwan and colleagues recently published research titled "Feasibility Testing of the ...
Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device ...
Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device (CF-LVAD) to sustain heart function. However, despite improvements managing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback